DR Horton (Germany) Performance
| HO2 Stock | EUR 134.10 2.98 2.27% |
The firm owns a Beta (Systematic Risk) of -0.0014, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning DR Horton are expected to decrease at a much lower rate. During the bear market, DR Horton is likely to outperform the market. At this point, DR Horton has a negative expected return of -0.35%. Please make sure to confirm DR Horton's mean deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if DR Horton performance from the past will be repeated sooner or later.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days DR Horton has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 3.2 B | |
| Total Cashflows From Investing Activities | -414.9 M |
HO2 |
DR Horton Relative Risk vs. Return Landscape
If you would invest 17,256 in DR Horton on September 24, 2024 and sell it today you would lose (3,846) from holding DR Horton or give up 22.29% of portfolio value over 90 days. DR Horton is currently producing negative expected returns and takes up 2.5742% volatility of returns over 90 trading days. Put another way, 22% of traded stocks are less volatile than HO2, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
DR Horton Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for DR Horton's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as DR Horton, and traders can use it to determine the average amount a DR Horton's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1373
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HO2 |
Estimated Market Risk
| 2.57 actual daily | 22 78% of assets are more volatile |
Expected Return
| -0.35 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average DR Horton is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DR Horton by adding DR Horton to a well-diversified portfolio.
DR Horton Fundamentals Growth
HO2 Stock prices reflect investors' perceptions of the future prospects and financial health of DR Horton, and DR Horton fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on HO2 Stock performance.
| Return On Equity | 0.31 | |||
| Return On Asset | 0.17 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 31.96 B | |||
| Shares Outstanding | 343.39 M | |||
| Price To Earning | 9.45 X | |||
| Price To Book | 1.53 X | |||
| Price To Sales | 0.87 X | |||
| Revenue | 33.48 B | |||
| EBITDA | 7.65 B | |||
| Cash And Equivalents | 637.7 M | |||
| Cash Per Share | 1.71 X | |||
| Total Debt | 6.07 B | |||
| Debt To Equity | 37.90 % | |||
| Book Value Per Share | 58.71 X | |||
| Cash Flow From Operations | 561.8 M | |||
| Earnings Per Share | 15.11 X | |||
| Total Asset | 30.35 B | |||
About DR Horton Performance
By analyzing DR Horton's fundamental ratios, stakeholders can gain valuable insights into DR Horton's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if DR Horton has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if DR Horton has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Horton, Inc. operates as a homebuilding company in East, Midwest, Southeast, South Central, Southwest, and West regions in the United States. Horton, Inc. was founded in 1978 and is based in Arlington, Texas. D R operates under Residential Construction classification in Germany and is traded on Frankfurt Stock Exchange. It employs 8437 people.Things to note about DR Horton performance evaluation
Checking the ongoing alerts about DR Horton for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for DR Horton help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| DR Horton generated a negative expected return over the last 90 days | |
| Over 89.0% of the company shares are owned by institutional investors |
- Analyzing DR Horton's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether DR Horton's stock is overvalued or undervalued compared to its peers.
- Examining DR Horton's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating DR Horton's management team can have a significant impact on its success or failure. Reviewing the track record and experience of DR Horton's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of DR Horton's stock. These opinions can provide insight into DR Horton's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for HO2 Stock analysis
When running DR Horton's price analysis, check to measure DR Horton's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DR Horton is operating at the current time. Most of DR Horton's value examination focuses on studying past and present price action to predict the probability of DR Horton's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DR Horton's price. Additionally, you may evaluate how the addition of DR Horton to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |